Scancell Holdings plc

Scancell Holdings plcverified

SCLP.L

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine against the SARS...[Read more]

Industry

Biotechnology

IPO Date

2010-02-12

Stock Exchange

LSE

Ticker

SCLP.L

The Enterprise Value as of December 2025 (TTM) for Scancell Holdings plc (SCLP.L) is 102.11M

According to Scancell Holdings plc’s latest financial reports and current stock price. The company's current Enterprise Value is 102.11M. This represents a change of -4.53% compared to the average of 106.96M of the last 4 quarters.

Scancell Holdings plc (SCLP.L) Historical Enterprise Value (quarterly & annually)

How has SCLP.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Scancell Holdings plc over the last ten years is 70.37M. The current 102.11M Enterprise Value has changed 14.41% with respect to the historical average. Over the past ten years (40 quarters), SCLP.L's Enterprise Value was at its highest in in the April 2021 quarter at 137.02M. The Enterprise Value was at its lowest in in the April 2007 quarter at -1504938.00.

Quarterly (TTM)
Annual

Average

70.37M

Median

57.38M

Minimum

15.76M

Maximum

161.10M

Scancell Holdings plc (SCLP.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Scancell Holdings plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 391.61%

Maximum Annual Enterprise Value = 161.10M

Minimum Annual Increase = -47.21%

Minimum Annual Enterprise Value = 15.76M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025103.68M26.47%
202481.98M-35.51%
2023127.13M35.33%
202293.94M-41.69%
2021161.10M391.61%
202032.77M107.87%
201915.76M-43.37%
201827.84M-5.15%
201729.35M-2.64%
201630.14M-47.21%

Scancell Holdings plc (SCLP.L) Average Enterprise Value

How has SCLP.L Enterprise Value performed in the past?

The current Enterprise Value of Scancell Holdings plc (SCLP.L) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

104.26M

5-year avg

113.57M

10-year avg

70.37M

Scancell Holdings plc (SCLP.L) Enterprise Value vs. Peers

How is SCLP.L’s Enterprise Value compared to its peers?

Scancell Holdings plc’s Enterprise Value is greater than 4basebio PLC (94.62M), greater than Bioventix PLC (83.74M), greater than ImmuPharma plc (30.05M), greater than Ondine Biomedical Inc. (71.33M), less than Shield Therapeutics plc (125.07M), greater than Hemogenyx Pharmaceuticals Plc (37.91M), greater than EKF Diagnostics Holdings plc (82.41M), greater than hVIVO plc (5.83M), greater than SkinBioTherapeutics Plc (34.72M), greater than BATM Advanced Communications Ltd. (86.74M),

Build a custom stock screener for Scancell Holdings plc (SCLP.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scancell Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scancell Holdings plc (SCLP.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scancell Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Scancell Holdings plc's Enterprise Value?

What is the highest Enterprise Value for Scancell Holdings plc (SCLP.L)?

What is the 3-year average Enterprise Value for Scancell Holdings plc (SCLP.L)?

What is the 5-year average Enterprise Value for Scancell Holdings plc (SCLP.L)?

How does the current Enterprise Value for Scancell Holdings plc (SCLP.L) compare to its historical average?